Volitionrx (VNRX) Convertible Debt (2025)

Name: Volitionrx (VNRX) Convertible Debt (2025) | Business Quant
Creator: Business Quant

Volitionrx posted quarterly Convertible Debt of $1.4 million for Q4 2025, down 36.32% on a QoQ basis from $2.3 million in Q3 2025.

Volitionrx (VNRX) has 1 years of Convertible Debt data on file, last reported at $1.4 million in Q4 2025.

For the quarter ending Q4 2025, Convertible Debt changed N/A year-over-year to $1.4 million; the trailing twelve-month figure through Dec 2025 stood at $1.4 million (changed N/A YoY), and the FY2025 full-year result was $1.4 million, changed N/A from the prior year.
Convertible Debt for Q4 2025 stood at $1.4 million, down from $2.3 million in the prior quarter.
Across five years, Convertible Debt topped out at $2.9 million in Q2 2025 and bottomed at $1.4 million in Q4 2025.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	152.82 Bn	146.17 Bn	6.27 Bn
2	Stryker	115.07 Bn	112.19 Bn	3.81 Bn
3	Medtronic	95.25 Bn	87.08 Bn	5.76 Bn
4	Boston Scientific	71.38 Bn	70.17 Bn	3.61 Bn
5	Edwards Lifesciences	51.08 Bn	47.41 Bn	1.29 Bn
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn
7	Dexcom	28.84 Bn	27.72 Bn	750.30 Mn
8	GE HealthCare Technologies	28.56 Bn	26.49 Bn	1.98 Bn
9	Steris	20.71 Bn	20.30 Bn	697.10 Mn
10	Volitionrx	101.83 Mn	99.36 Mn	-1.01 Mn

Download Data 🔒